Haru Morita
Founder at MODALIS THERAPEUTICS CORPORATION
Net worth: 3 M $ as of 2024-04-29
Profile
Haru Morita is the founder of REGiMMUNE Corp.
(founded in 2006) and Modalis Therapeutics Corp.
(founded in 2016, where he is currently the President, CEO & Representative Director).
He is currently the Chief Executive Officer at Modalis Therapeutics, Inc. (since 2016).
Mr. Morita's former positions include Director-Business Development at Y's Therapeutics, Inc., Research Scientist at Kirin Brewery Co. Ltd., and Principal at Booz Allen Hamilton International (U.K.) Ltd.
Mr. Morita received his undergraduate and graduate degrees from the School of Engineering, The University of Tokyo.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-12-30 | 6,026,300 ( 16.38% ) | 3 M $ | 2024-04-29 |
Haru Morita active positions
Companies | Position | Start |
---|---|---|
MODALIS THERAPEUTICS CORPORATION | Founder | 2015-12-31 |
Modalis Therapeutics, Inc. | Chief Executive Officer | 2016-03-31 |
Former positions of Haru Morita
Companies | Position | End |
---|---|---|
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Chief Executive Officer | - |
Booz Allen Hamilton International (U.K.) Ltd.
Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Corporate Officer/Principal | - |
Kirin Brewery Co. Ltd.
Kirin Brewery Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Kirin Brewery Co., Ltd. engages in the manufacture of alcoholic beverages. Its products include beer, sparkling liquor, chuhai, gin, and whiskey. The company was founded in 1901 and is headquartered in Tokyo, Japan. | Chief Tech/Sci/R&D Officer | - |
Y's Therapeutics, Inc.
Y's Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Y's Therapeutics, Inc. manufactures biopharmaceuticals. | Corporate Officer/Principal | - |
Training of Haru Morita
School of Engineering, The University of Tokyo | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MODALIS THERAPEUTICS CORPORATION | Health Technology |
Private companies | 5 |
---|---|
Y's Therapeutics, Inc.
Y's Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Y's Therapeutics, Inc. manufactures biopharmaceuticals. | Health Technology |
Kirin Brewery Co. Ltd.
Kirin Brewery Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Kirin Brewery Co., Ltd. engages in the manufacture of alcoholic beverages. Its products include beer, sparkling liquor, chuhai, gin, and whiskey. The company was founded in 1901 and is headquartered in Tokyo, Japan. | Consumer Non-Durables |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
Booz Allen Hamilton International (U.K.) Ltd.
Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Commercial Services |
Modalis Therapeutics, Inc. |
- Stock Market
- Insiders
- Haru Morita